Home
EOLS
EOLS News

Latest Evolus Inc. (EOLS) News on July 8, 2024

Evolus Announces Appointment of Albert G. White III to Board of Directors

Business Wire

7 days ago

Evolus Announces Appointment of Albert G. White III to Board of Directors

MT Newswires

14 days ago

Evolus Completes FDA Premarket Approval Submission for Evolysse Dermal Fillers for 'Smile Lines'

Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products

Business Wire

14 days ago

Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products

Market Sentiment Around Loss-Making Evolus, Inc. (NASDAQ:EOLS)

Simply Wall St.

19 days ago

Market Sentiment Around Loss-Making Evolus, Inc. (NASDAQ:EOLS)

Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain

Business Wire

a month ago

Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

GuruFocus.com

a month ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

Camber Energy Announces Passing of Director Lawrence Fisher

ACCESSWIRE

a month ago

Camber Energy Announces Passing of Director Lawrence Fisher

ThreeD Capital Inc. Announces Unaudited May 31, 2024 Net Asset Value Per Share - $0.72

GlobeNewswire

a month ago

ThreeD Capital Inc. Announces Unaudited May 31, 2024 Net Asset Value Per Share - $0.72

Ciscom Corp. to Hold Annual and Special Meeting of the Shareholders on August 20, 2024

Newsfile

a month ago

Ciscom Corp. to Hold Annual and Special Meeting of the Shareholders on August 20, 2024

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a month ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q

Media Advisory - Prime Minister's itinerary for Saturday, June 8, 2024

CNW Group

a month ago

Media Advisory - Prime Minister's itinerary for Saturday, June 8, 2024

CORUS PROVIDES UPDATE ON PROGRAMMING AND TRADEMARK OUTPUT ARRANGEMENTS

CNW Group

a month ago

CORUS PROVIDES UPDATE ON PROGRAMMING AND TRADEMARK OUTPUT ARRANGEMENTS

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

a month ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 06/07/2024

The Evolution of Medical Aesthetics and Its Growing Foothold in the Beauty Space

WWD

a month ago

The Evolution of Medical Aesthetics and Its Growing Foothold in the Beauty Space

Evolus (EOLS) Releases Favorable Dermal Fillers Study Data

Zacks

2 months ago

Evolus (EOLS) Releases Favorable Dermal Fillers Study Data

Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting

Business Wire

2 months ago

Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting

Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS)

GuruFocus.com

2 months ago

Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS)

Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS)

GuruFocus.com

2 months ago

Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS)

Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit

Business Wire

2 months ago

Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 months ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year

Business Wire

2 months ago

Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year

Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

2 months ago

Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript

Insider Monkey

2 months ago

Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Evolus Inc Earnings Call

GuruFocus.com

2 months ago

Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

2 months ago

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth

GuruFocus.com

2 months ago

Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth

Evolus Reports First Quarter 2024 Results and Provides Business Update

Business Wire

2 months ago

Evolus Reports First Quarter 2024 Results and Provides Business Update

The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59%

Simply Wall St.

2 months ago

The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59%

Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?

Zacks

2 months ago

Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?

Evolus to Report First Quarter Financial Results on May 7, 2024

Business Wire

3 months ago

Evolus to Report First Quarter Financial Results on May 7, 2024

11 Best Low Price Pharma Stocks To Invest In

Insider Monkey

3 months ago

11 Best Low Price Pharma Stocks To Invest In

Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®

Business Wire

3 months ago

Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company

Simply Wall St.

3 months ago

Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company

Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

3 months ago

Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference

10 Stocks George Soros and Insiders Are Crazy About

Insider Monkey

4 months ago

10 Stocks George Soros and Insiders Are Crazy About

Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?

Zacks

4 months ago

Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?

Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock

Business Wire

4 months ago

Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock

Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report

Simply Wall St.

4 months ago

Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report

Evolus Full Year 2023 Earnings: In Line With Expectations

Simply Wall St.

4 months ago

Evolus Full Year 2023 Earnings: In Line With Expectations

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Evolus Inc Earnings Call

Evolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024

GuruFocus.com

4 months ago

Evolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024

Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance

Business Wire

4 months ago

Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance

11 Best Small Cap Pharma Stocks to Invest In

Insider Monkey

4 months ago

11 Best Small Cap Pharma Stocks to Invest In

Evolus Announces Results from European Head-to-Head Filler Trial

Business Wire

4 months ago

Evolus Announces Results from European Head-to-Head Filler Trial

Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences

Business Wire

4 months ago

Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences

Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024

Business Wire

5 months ago

Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus Inc Director Karah Parschauer Sells 11,931 Shares

GuruFocus.com

5 months ago

Evolus Inc Director Karah Parschauer Sells 11,931 Shares

Oceaneering International (OII) Gains But Lags Market: What You Should Know

Zacks

5 months ago

Oceaneering International (OII) Gains But Lags Market: What You Should Know

Why IBM's new retirement plan has the industry buzzing

Yahoo Finance Video

5 months ago

Why IBM's new retirement plan has the industry buzzing

Archrock Increases Quarterly Cash Dividend

GlobeNewswire

5 months ago

Archrock Increases Quarterly Cash Dividend

Evolus Insider Ups Holding By 210% During Year

Simply Wall St.

5 months ago

Evolus Insider Ups Holding By 210% During Year

Cinemark’s Annual Oscar® Movie Week Festival Brings Prestigious Hollywood Films to Auditoriums Across the Nation

Business Wire

6 months ago

Cinemark’s Annual Oscar® Movie Week Festival Brings Prestigious Hollywood Films to Auditoriums Across the Nation

Century Communities Announces Acquisition of Greater Nashville Builder: Landmark Homes of Tennessee, Inc.

PR Newswire

6 months ago

Century Communities Announces Acquisition of Greater Nashville Builder: Landmark Homes of Tennessee, Inc.

Northwest Bancshares Inc Reports Mixed Q4 Results Amid Interest Rate and Liquidity Challenges

GuruFocus.com

6 months ago

Northwest Bancshares Inc Reports Mixed Q4 Results Amid Interest Rate and Liquidity Challenges

LTC Properties Inc's Dividend Analysis

GuruFocus.com

6 months ago

LTC Properties Inc's Dividend Analysis

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance

Business Wire

6 months ago

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 Overlooked Stocks Poised for Extraordinary 10X Growth

InvestorPlace

6 months ago

3 Overlooked Stocks Poised for Extraordinary 10X Growth

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

ACCESSWIRE

6 months ago

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

Vista Outdoor to Release Third Quarter Fiscal Year 2024 Financial Results

Business Wire

6 months ago

Vista Outdoor to Release Third Quarter Fiscal Year 2024 Financial Results

Is There Now An Opportunity In LKQ Corporation (NASDAQ:LKQ)?

Simply Wall St.

6 months ago

Is There Now An Opportunity In LKQ Corporation (NASDAQ:LKQ)?

Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This High?

Zacks

6 months ago

Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This High?

Wolverine (WWW) Announces Its Preliminary Results for 2023

Zacks

6 months ago

Wolverine (WWW) Announces Its Preliminary Results for 2023

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?

Simply Wall St.

6 months ago

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?

Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications

Business Wire

6 months ago

Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications

Business Wire

6 months ago

Black Rifle Coffee Company to Participate in the 2024 ICR Conference

New Strong Buy Stocks for January 2nd

Zacks

6 months ago

New Strong Buy Stocks for January 2nd

Is LKQ Corporation's (NASDAQ:LKQ) Stock's Recent Performance A Reflection Of Its Financial Health?

Simply Wall St.

6 months ago

Is LKQ Corporation's (NASDAQ:LKQ) Stock's Recent Performance A Reflection Of Its Financial Health?

GuruFocus.com

7 months ago

Worthington Steel Inc Reports Mixed Fiscal Q2 2024 Results Amidst Market Challenges

Associated Press Finance

7 months ago

Worthington: Fiscal Q2 Earnings Snapshot

Thomson Reuters StreetEvents

7 months ago

Q2 2024 Worthington Enterprises Inc Earnings Call

Are Options Traders Betting on a Big Move in Worthington Enterprises (WOR) Stock?

Zacks

7 months ago

Are Options Traders Betting on a Big Move in Worthington Enterprises (WOR) Stock?

4 Stocks to Watch From the Prospering Technology Solutions Industry

Zacks

7 months ago

4 Stocks to Watch From the Prospering Technology Solutions Industry

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Business Wire

7 months ago

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Chesapeake Utilities' (CPK) Unit Buys Propane Operating Assets

Zacks

7 months ago

Chesapeake Utilities' (CPK) Unit Buys Propane Operating Assets

MFA Financial, Inc. Announces Dividend of $0.35 per Share

Business Wire

7 months ago

MFA Financial, Inc. Announces Dividend of $0.35 per Share

Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial

GlobeNewswire

7 months ago

Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial

IES Holdings Promotes Matthew Simmes to President and Chief Operating Officer

GlobeNewswire

7 months ago

IES Holdings Promotes Matthew Simmes to President and Chief Operating Officer

MeridianLink Product Innovator Named as National Mortgage Professional 40 Under 40 Winner

Business Wire

7 months ago

MeridianLink Product Innovator Named as National Mortgage Professional 40 Under 40 Winner

Argentina’s New President Wants to Adopt the U.S. Dollar as the National Currency

The Wall Street Journal

8 months ago

Argentina’s New President Wants to Adopt the U.S. Dollar as the National Currency

Wall Street Analysts Predict a 33.08% Upside in Oddity Tech (ODD): Here's What You Should Know

Zacks

8 months ago

Wall Street Analysts Predict a 33.08% Upside in Oddity Tech (ODD): Here's What You Should Know

Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript

Business Wire

8 months ago

BRC Inc. Reports Third Quarter 2023 Financial Results

Business Wire

8 months ago

Black Rifle Coffee Company and UFC® Join the Fight Against Service-Related Illness with HunterSeven Foundation

Nexa Reports Third Quarter 2023 Net Loss of US$63 million and Adjusted EBITDA of US$82 Million

ACCESSWIRE

8 months ago

Nexa Reports Third Quarter 2023 Net Loss of US$63 million and Adjusted EBITDA of US$82 Million

Share on Social Networks: